Amgen (AMGN) Work In Process (2013 - 2017)

Amgen's Work In Process history runs 5 years deep, the most recent figure standing at $1.6 billion for Q2 2017.

• In Q2 2017, Work In Process changed N/A year-over-year to $1.6 billion; the TTM figure through Jun 2017 stood at $1.6 billion (changed N/A YoY), while the FY2016 annual figure was $1.6 billion, up 5.17% from the prior year.
• Work In Process was $1.6 billion for Q2 2017 at Amgen, up from $1.5 billion in the prior quarter.
• In the past five years, Work In Process ranged from a high of $2.1 billion in Q4 2013 to a low of $1.3 billion in Q2 2015.
• Historically, Work In Process has averaged $1.6 billion across 5 years, with a median of $1.6 billion in 2014.
• The sharpest annual moves came in 2015 and 2016: Work In Process dropped 28.1% in 2015, then gained 5.17% in 2016.
• A 5-year view of Work In Process shows it stood at $2.1 billion in 2013, then retreated by 24.85% to $1.6 billion in 2014, then decreased by 1.42% to $1.5 billion in 2015, then advanced by 5.17% to $1.6 billion in 2016, then grew by 0.62% to $1.6 billion in 2017.
• The last three Work In Process figures came in at $1.6 billion (Q2 2017), $1.5 billion (Q1 2017), and $1.6 billion (Q4 2016), per Business Quant data.